Skip to main content
Skip to main content
HAO logo

Haoxi Health Technology Limited (HAO) Stock Analysis

Educational signal · not a buy or sell recommendation · How to read this

$2.85 -$0.025 (-0.87%) |Weak · 33
Haoxi Health Technology Limited (HAO) bottom line: signals are mixed — the Council read leans Split View (42/100) while the AI fundamental score is 33/100 (grade D); the two lenses disagree, so weigh the breakdown below. Strongest signal: Ray Dalio bullish · Biggest watch-out: Seth Klarman bearish.Educational signal, not a buy or sell recommendation. Compare sector peers → · Read the method →
P/E Ratio: 0.82| Vol: 11.7K| 52-wk range: $2.70 – $5708.80

P/E 0.82 means the share price is 0.82 times one year of earnings per share; the S&P 500 usually sits near 20-25.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated May 31, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

Haoxi Health Technology Limited (HAO) trades at $2.85 with MoonshotScore 33/100 (Grade D). Haoxi Health Technology Limited provides online marketing solutions in China, primarily serving the healthcare industry. Sector: Communication services.

Price as of Sep 11, 2026 · Last analyzed: May 31, 2026
Haoxi Health Technology Limited provides online marketing solutions in China, primarily serving the healthcare industry. The company focuses on online short video marketing and customized advertising solutions across various online media platforms.

Analyst Coverage for HAO: HAO does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates HAO against Communication Services peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.

Watch the HAO film Every key number, told as a short cinematic story — just press play. ~2 min

These figures come from statements filed 15 months ago — the most recent this company has published.

Council Score · Weighted Average of 3 Disciplines
Split View 42/100 · C

HAO: 2/3 scored disciplines lean bearish. Dominant signal: Seth Klarman bearish.

How is this calculated? →
MoonshotScore · Five-pillar engine · 33/100
Business Quality
Negative Is this a genuinely good business?
Financial Safety
Strong Could this blow up on me?
Valuation
Neutral Am I paying a fair price?
Growth Durability
Neutral Is the growth real and likely to last?
Momentum
Negative Is the market already moving on this?

Strongest side: Financial Safety (8/10, Strong). Weakest side: Momentum (0/10, Negative).

Legends Council · 5 Legends + Moon AI

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated)Ray Dalio
Favorable read
Englander-style lens (simulated)Izzy Englander
Neutral read
Klarman-style lens (simulated)Seth Klarman
Unfavorable read
Moon AI lens (model)
Favorable read
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Negative
Margin of Safety
Undervalued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →
The lenses are modelled on the published principles of the investors named. We are not affiliated with them, they have not endorsed this, and it is not their opinion of this stock.

Why this analysis is different

  • A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
  • An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
  • Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Haoxi Health Technology Limited (HAO) Media & Communications Profile

CEOLei Xu
Employees26
HeadquartersBeijing, CN
IPO Year2024

Haoxi Health Technology Limited delivers online marketing solutions in China, specializing in short video and customized advertising for the healthcare sector. Utilizing platforms like Toutiao, Douyin, and WeChat, the company focuses on acquiring, converting, and retaining consumers through strategic ad placement and optimization, operating with a lean team of 30 employees.

Data Provenance | Financial Data Quantitative Analysis Analysis: May 31, 2026

What Is the Investment Thesis for HAO?

AI-written as of May 31, 2026 — figures and tone reflect the data available then, not today's score.

Haoxi Health Technology Limited presents a focused approach to online marketing within China's healthcare sector. The company's emphasis on short-video advertising and customized solutions leverages the increasing importance of digital channels for healthcare marketing. With a negative beta of -0.57, the stock may offer some diversification benefits. Key to the company's growth will be its ability to scale its operations and improve its profit margin, which currently stands at -6.5%. Growth catalysts include expanding its client base within the healthcare industry and further penetrating the online advertising market. However, investors should be aware of the risks associated with operating in a highly competitive market and the potential impact of regulatory changes in China. The company's ability to maintain and grow its market share will be crucial for long-term success.

Based on FMP financials and quantitative analysis

HAO Key Highlights

AI-written as of May 31, 2026 — figures and tone reflect the data available then, not today's score.

Haoxi Health Technology Limited operates in the online marketing solutions sector in China, focusing on the healthcare industry.

  • The company's online marketing solutions include short video marketing and customized advertising on platforms like Toutiao, Douyin, WeChat, and Sina Weibo.
  • Haoxi Health Technology Limited was founded in 2018 and is based in Beijing, China.
  • The company has a negative beta of -0.57, indicating a potential inverse correlation with the market.
  • Haoxi Health Technology Limited's profit margin is -6.5%, indicating that it is currently operating at a loss.

Who Are HAO's Competitors?

HAO is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
PUBGY Publicis Groupe S.A. $28.30 +1.43% $28.3B 499-signal
OMC Omnicom Group Inc. $79.04 -0.52% $21.7B 545-pillar
DNTUF Dentsu Group Inc. $24.61 0.00% $6.39B 529-signal
WPP WPP plc $24.77 -0.48% $5.34B 585-pillar
MGNI Magnite, Inc. $23.55 -0.13% $3.37B 745-pillar
HKUOY Hakuhodo DY Holdings Inc $17.35 0.00% $3.14B 509-signal
STGW Stagwell Inc. $8.57 +0.59% $2.12B 569-signal
CMPR Cimpress plc $84.78 +0.84% $2.05B 785-pillar

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.

What Are HAO's Key Strengths?

Focus on the healthcare industry provides a specialized market position.

  • Expertise in online short video marketing aligns with current trends.
  • Strategic partnerships with key online media platforms in China.
  • Customized marketing solutions tailored to client needs.

What Are HAO's Weaknesses?

Small company size (30 employees) may limit scalability.

  • Negative profit margin indicates financial challenges.
  • Limited geographic diversification, primarily based in Beijing.
  • Dependence on a single industry (healthcare) may increase vulnerability.

What Could Drive HAO Stock Higher?

Expansion of online marketing services within the healthcare industry.

  • Development of strategic partnerships with key online media platforms.
  • Potential for increased demand for online advertising solutions in the healthcare sector.
  • Leveraging data analytics to improve ad targeting and ROI.

What Are the Key Risks for HAO?

Negative return on equity (-16.6%) — the business is not currently generating profit on shareholder capital.

  • Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
  • Intense competition in the online advertising industry.
  • Regulatory changes in China affecting online advertising.
  • Economic downturn impacting advertising budgets.
  • Dependence on a single industry (healthcare) may increase vulnerability.

What Are the Growth Opportunities for HAO?

  • Growth opportunity 1: Expanding services to new healthcare sub-sectors represents a significant growth opportunity for Haoxi Health. The healthcare industry is diverse, encompassing pharmaceuticals, medical devices, hospitals, and wellness products. By tailoring its marketing solutions to the specific needs of each sub-sector, Haoxi Health can tap into new revenue streams. The market size for healthcare advertising in China is substantial, estimated to be worth billions of dollars annually. Timeline: Ongoing, with continuous adaptation to evolving healthcare needs.
  • Growth opportunity 2: Leveraging data analytics to improve ad targeting and ROI is crucial for Haoxi Health. By analyzing user data and campaign performance, the company can optimize its ad placements and messaging to maximize conversions. The market for data analytics in advertising is growing rapidly, driven by the increasing availability of data and the demand for more effective marketing strategies. Implementing advanced analytics tools and techniques will enable Haoxi Health to deliver better results for its clients and differentiate itself from competitors. Timeline: Within the next 12-18 months.
  • Growth opportunity 3: Forming strategic partnerships with key online media platforms can enhance Haoxi Health's reach and influence. Collaborating with platforms like Douyin, WeChat, and Sina Weibo can provide access to a wider audience and enable the company to offer more integrated marketing solutions. These partnerships can also lead to preferential ad rates and placement opportunities. The market for online media partnerships is competitive, but the potential benefits are significant. Timeline: Ongoing, with continuous exploration of new partnership opportunities.
  • Growth opportunity 4: Developing proprietary marketing technology can provide Haoxi Health with a competitive edge. Creating tools for ad creation, optimization, and reporting can streamline the marketing process and improve efficiency. This technology can also be licensed to other companies, generating additional revenue streams. The market for marketing technology is rapidly evolving, with new solutions emerging constantly. Investing in R&D and developing innovative technology will be essential for Haoxi Health to stay ahead of the curve. Timeline: Within the next 24-36 months.
  • Growth opportunity 5: Expanding geographically within China can unlock new markets and customer segments. While Haoxi Health is currently based in Beijing, there are numerous other regions with significant growth potential. By establishing a presence in these regions, the company can tap into new customer bases and diversify its revenue streams. The market for online advertising varies across different regions in China, with some areas being more developed than others. Careful market research and strategic planning will be essential for successful geographic expansion. Timeline: Within the next 36-48 months.

What Are HAO's Competitive Advantages?

  • Specialization in the healthcare industry provides a niche market focus.
  • Expertise in online short video marketing caters to current consumer trends.
  • Relationships with key online media platforms in China offer access to a broad audience.

What Does HAO Do?

Founded in 2018 and based in Beijing, China, Haoxi Health Technology Limited operates in the rapidly evolving landscape of online marketing. The company focuses on providing comprehensive online marketing solutions, with a strong emphasis on the healthcare industry. Haoxi Health's services include online short video marketing solutions, which are delivered through strategic partnerships with various media platforms. These solutions enable advertisers to reach a broad audience through engaging video content. In addition to short video marketing, Haoxi Health offers customized marketing solutions tailored to the specific needs of its clients. These solutions encompass the entire advertising process, from initial planning and production to ad placement and ongoing optimization. By leveraging data-driven insights, Haoxi Health aims to help advertisers effectively acquire, convert, and retain consumers across diverse online media platforms. The company strategically places ads on popular platforms such as Toutiao, Douyin, WeChat, and Sina Weibo, ensuring maximum visibility and engagement for its clients. Haoxi Health's commitment to innovation and its focus on the healthcare industry have allowed it to carve out a niche in the competitive online marketing sector. Despite its relatively short history, the company has demonstrated a capacity to adapt to changing market dynamics and deliver value to its clients through effective and targeted marketing campaigns.

What Products and Services Does HAO Offer?

  • Provides online marketing solutions in China.
  • Offers online short video marketing solutions to advertisers.
  • Delivers customized marketing solutions by planning, producing, placing, and optimizing online ads.
  • Helps advertisers acquire, convert, and retain consumers on various online media platforms.
  • Places ads through mainstream online short video and social media platforms, such as Toutiao, Douyin, WeChat, and Sina Weibo.
  • Serves advertiser client base primarily in the healthcare industry.

How Does HAO Make Money?

  • Generates revenue by providing online marketing solutions to advertisers.
  • Offers customized marketing solutions by planning, producing, placing, and optimizing online ads.
  • Partners with media platforms to place ads and reach target audiences.

What Industry Does HAO Operate In?

Haoxi Health Technology Limited operates within the dynamic and rapidly expanding online advertising industry in China. The industry is characterized by intense competition, technological innovation, and evolving consumer preferences. The shift towards mobile and short-form video content has created significant opportunities for companies like Haoxi Health that specialize in these areas. The Chinese advertising market is one of the largest globally, with digital advertising accounting for a significant portion of total ad spend. Key players in the industry include large tech companies, established advertising agencies, and emerging startups. Haoxi Health's focus on the healthcare sector provides a degree of specialization, but the company must continue to innovate and adapt to stay ahead of the competition.

Who Are HAO's Key Customers?

  • Advertisers in the healthcare industry.
  • Companies seeking to acquire, convert, and retain consumers online.
  • Businesses looking to leverage short video and social media platforms for marketing.
Model self-rating on this text: 66% (not a measure of the evidence) Updated: May 31, 2026

Research confidence

Medium 74/100

Enough evidence to be useful, with gaps worth knowing about.

  • Scored on 100% of our measures
  • Price is current
  • Latest filing 142 days ago
  • No analyst coverage

Why 33?

Measured against companies in the same sector. The figures below are the factor contributions the scoring engine itself produced.

What is helping

  • +0.56 Volatility vs the market (Financial Strength)
  • +0.54 Enterprise value vs free cash flow (Valuation)
  • +0.54 Price to book (Valuation)

What is holding it back

  • -0.78 Return on invested capital (Business Quality)
  • -0.78 Free cash flow yield (Business Quality)
  • -0.54 Earnings yield (Valuation)

Risk penalties applied

  • -1.25 Loss-making with negative retained earnings

Contribution = how far the company sits from its sector on that measure, weighted by how much the pillar counts. Not investment advice. How the score is built →

MoonshotScore History

Recorded daily since 2026-08-23 · 19 snapshots

2026-08-23 35
2026-08-26 35
2026-08-29 35
2026-09-01 33
2026-09-04 33
2026-09-07 33
2026-09-10 33

What changed?

The grade moved from 35 to 33 (-2).

Over the same 18 days the stock moved -12.8%.

Company Profile

Haoxi Health Technology Limited operates in the Advertising Agencies industry within the Communication Services sector. It is headquartered in Beijing, CN. The company is led by CEO Zhen Fan. HAO has traded publicly since 2024.

Haoxi Health Technology Limited Financial Trajectory

Haoxi Health Technology Limited (HAO) reported $33.8M in revenue for Q2 FY2026, reflecting 282.3% growth compared to the prior quarter. The company recorded a net loss of $6.9M, with diluted EPS of $-30.67. Quarter-over-quarter revenue has been mixed, typical for a unknown company operating in Communication Services. Across the four most recent quarters, HAO averaged $-0.43 in diluted EPS.

How Haoxi Health Technology Limited Is Valued

Relative to its peer group, HAO's quantitative score of 33/100 is below the peer average of 59/100.

ROE -17%

Key Financial Metrics

Return on equity for Haoxi Health Technology Limited stands at -16.6%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -13.4%, showing how much profit it generates from its asset base. A current ratio of 3.45 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -60.0%, the inverse of the P/E and a quick read on earnings relative to price.

F-Score 3/9

Financial Health

Haoxi Health Technology Limited's Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 4.98 places it in the safe zone, indicating low near-term bankruptcy risk.

HAO Financials

Fundamental Snapshot

Revenue Growth (FY)
-32.4%
Net Income Growth (FY)
+200.1%
EPS Growth (FY)
+56.6%
Free Cash Flow Growth (FY)
-318.2%
P/E (TTM)
0.82
Return on Equity (TTM)
-16.6%
Current Ratio
3.5
EV/EBITDA (TTM)
4.2

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • Focus on the healthcare industry provides a specialized market position.
  • Expertise in online short video marketing aligns with current trends.
  • Strategic partnerships with key online media platforms in China.
  • Customized marketing solutions tailored to client needs.

Bear Case

  • Small company size (30 employees) may limit scalability.
  • Negative profit margin indicates financial challenges.
  • Limited geographic diversification, primarily based in Beijing.
  • Dependence on a single industry (healthcare) may increase vulnerability.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · September 2026

Recent Quarterly Results

Quarter Revenue Net Income EPS
Q2 FY2026 $34M -$7M -$30.67
Q4 FY2025 $9M $4M $28.37
Q2 FY2025 $24M -$232,533 -$0.26
Q4 FY2024 $25M $529,802 $0.84

Q2 FY2026 · filed 22 Apr 2026 · SEC EDGAR →

Based on FMP financials and quantitative analysis

HAO Latest News

HAO Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for HAO.

Price Targets

Wall Street price target analysis for HAO.

HAO MoonshotScore

33/100

What does this score mean?

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. HAO scores 33/100 (Grade D): the number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers.

Latest Haoxi Health Technology Limited Analysis

Leadership: Lei Xu

CEO

Lei Xu is the CEO of Haoxi Health Technology Limited. However, as the CEO of a technology company founded in 2018, it is likely that Lei Xu has a background in marketing, technology, or business management. His leadership is crucial for guiding the company's strategic direction and growth in the competitive online advertising market in China.

Track Record: As CEO, Lei Xu manages 30 employees. Specific details regarding key achievements, strategic decisions, and company milestones under Lei Xu's leadership are not available in the provided data. However, founding and leading a company in the dynamic online marketing sector requires adaptability, strategic vision, and effective execution. His focus on the healthcare industry and online short video marketing reflects a keen understanding of market trends and consumer preferences.

Common Questions About HAO (Communication Services)

What does the AI Score mean for HAO?

HAO holds an AI Score of 33/100 (Grade: D). This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers. Haoxi Health Technology Limited provides online marketing solutions in China, primarily serving the healthcare industry.

Is HAO a good stock?

Stock Expert AI does not rate HAO buy, sell or hold. Haoxi Health Technology Limited carries a MoonshotScore of 33/100 on the five-pillar engine, a research rating against its peers. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.

What do analysts say about HAO stock?

There is no analyst coverage information provided. Therefore, there is no analyst consensus, valuation metrics, or growth considerations available. Further research would be needed to determine analyst sentiment and potential investment considerations.

What are the key factors to evaluate for HAO?

Haoxi Health Technology Limited (HAO) holds a MoonshotScore of 33/100 (low). P/E: 0.82x vs the S&P 500's ~20-25x. Not financial advice.

How frequently does HAO data refresh on this page?

HAO's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.

What has driven HAO's recent stock price performance?

Haoxi Health Technology Limited (HAO) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Focus on the healthcare industry provides a specialized market position. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider HAO overvalued or undervalued right now?

Haoxi Health Technology Limited (HAO) trades at 0.82x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Can I buy fractional shares of HAO?

Yes, most major brokerages offer fractional shares of Haoxi Health Technology Limited (HAO) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track HAO's earnings and financial reports?

Haoxi Health Technology Limited (HAO) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for HAO earnings announcements.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated MoonshotScore as of
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Information is based on limited data provided.
  • Financial metrics may not be up-to-date.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis

More Stocks We Cover